ArticleBMC microbiology2026
Diagnostic accuracy of chip hybridization from formalin-fixed paraffin embedded bioptic specimens in a cohort with predominantly extrapulmonary mycobacterial disease.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionExtrapulmonary tuberculosis (TB) and non-tuberculous mycobacterial (NTM) disease remain a diagnostic challenge and conventional methods such as mycobacterial culture or molecular methods (e.g. GeneXpert) performed on formalin-fixed paraffin embedded (FFPE) specimens are often unsuccessful. In this study, we assessed the diagnostic accuracy of chip hybridization from FFPE specimens in a cohort with predominantly extrapulmonary mycobacterial disease.
methodsFFPE specimens from patients with presumed mycobacterial disease underwent chip hybridization with two different assays (MYCO Direct 1.7 and MYCO Chip Vision Array 2.0) in addition to conventional diagnostic methods for TB and NTM disease including mycobacterial culture, molecular methods and conventional histology. The different techniques were assessed with regards to sensitivity, specificity and species identification.
resultsOverall, 184 samples were assessed by one of the two chip hybridization techniques (MYCO Direct 1.7 n=65 and MYCO Chip Vision Array n=119). Samples were mainly extrapulmonary (160/184, 87.0%). Of all samples, 32 (17.4%) turned positive in chip hybridization and 74/184 patients (40.2%) were diagnosed with clinically relevant mycobacterial disease (59 with TB and 15 with NTM disease). For the detection of Mycobacterium tuberculosis complex (MTBC), sensitivity was 38.9% when compared to mycobacterial culture from the same specimen. For the detection of NTM, sensitivity was 50% against NTM culture. Species identification was overall consistent with conventional methods but did not allow for species differentiation of members of the MTBC or Mycobacterium avium complex, respectively.
conclusionAs extrapulmonary TB and NTM disease remain a diagnostic challenge, the investigated chip hybridization techniques might present a complementation of the diagnostic portfolio. However, with a low sensitivity to detect MTB from extrapulmonary FFPE specimens, they should not supplant conventional diagnostic methods but could be used to rule in TB when native specimens are not available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.